Search Within

Maria Michelle Rubinstein

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (17)
  2. Epidemiology and Biostatistics (17)
  3. GDMT, Medicine (17)
  4. Gynecologic Medicine Service (17)
  5. Gynecology Disease Management Team (17)
  6. Solid Tumor Oncology Division (17)

More Groups

People
  1. Alexia Iasonos (15)
  2. Carol Aghajanian (15)
  3. Vicky Makker (15)
  4. Qin Zhou (13)
  5. Rachel Grisham (11)
  6. Claire Friedman (9)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (3)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (2)

More Years

Publications
  1. Gynecologic Oncology (5)
  2. Journal of Clinical Oncology (3)
  3. Clinical Cancer Research (2)
  4. International Journal of Gynecological Cancer (2)
  5. Cancer (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. Elsevier Inc. (5)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (3)
  4. Lippincott Williams & Wilkins (2)
  5. Biomed Central Ltd (1)
  6. Nature Publishing Group (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Bevacizumab in advanced endometrial cancer
    Journal Article

    Rubinstein, M. M.; Dickinson, S.; Narayan, P.; Zhou, Q.; Iasonos, A.; Ma, W.; Lakhman, Y.; Makker, V.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
    Journal Article

    Rubinstein, M. M.; Grisham, R. N.; Cadoo, K.; Kyi, C.; Tew, W. P.; Friedman, C. F.; O'Cearbhaill, R. E.; Zamarin, D.; Zhou, Q.; Iasonos, A.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Single-arm, open-label, phase II study of LY3023414 for the treatment of recurrent or persistent endometrial cancer
    Meeting Abstract

    Rubinstein, M. M.; Hyman, D.; Caird, I.; O'Cearbhaill, R.; Grisham, R.; Tew, W.; Hensley, M.; Sabbatini, P.; Aghajanian, C.; Iasonos, A.; more...
    Molecular Cancer Research (2020)

    Fulltext@MSK | Save
  • Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
    Journal Article

    Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save